Showing:
◈ medical devices×
There are supply issues with medical devices, fuel and food costs.
The chief pharmaceutical officer has warned that without mitigation, the supply of medicines and medical devices into Northern Ireland would be considered a "very high risk area".
The Brexit predictions that came true, those that didn’t—and what we didn’t see coming - BMJ
03/08/2022
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Nuffield Trust: Slow decisions and vague trade slogans leave NHS uncertain of post-Brexit future
20/12/2021
Our report published today looks at six key areas of health and social care that are being impacted by Brexit.
The UK should implement new EU medical device regulation into legislation post Brexit transition - Poll
29/03/2021
The new European Union (EU) Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) are due to be implemented across the EU from May 2021.
The prime minister has imperilled peace in Northern Ireland, and every day the economic fallout worsens.
Brexit could have major implications for health and social care in England. Here we look at some of the latest developments that could have an impact.
Medical devices in the UK will lack adequate safety standards until new post-Brexit regulations come into effect: Poll
22/03/2021
Verdict has conducted a poll to analyse whether medical devices in the UK will continue to have a high degree of safety until all new post-Brexit regulations come into effect by 2023.
For new medical devices entering the UK market, they will only need to comply with the old, and for some, less stringent, device standard (MDR, 2002). / ... Coupled with the additional authorisation process required to reach the UK market, this may lead to delays or deter companies from selling their products in the UK altogether.
For almost 50 years, the NHS benefited from easy access to a large market, meaning it’s been first in the queue for the latest innovations. But what impact might Brexit have on medicines, medical devices and life sciences in the UK? Mark Dayan explains, in a blog that was first published in the BMJ on 26 February.
From 1 January 2021, the medical device regulatory landscape in the UK changed. The regulatory structure for medical devices is very complicated and fragmented. / Listed below are the old and new medical device regulations in EU and the UK, as identified by GlobalData.
With it still possible the United Kingdom will leave the European Union without a deal, Mark Dayan looks at the impact that would have on NHS costs.
Brexit disruption to medicine supply lines would be unacceptable, Health Minister Robin Swann says
22/04/2021
Health Minister Robin Swann has voiced concern about the supply line of medicines to Northern Ireland as a result of a looming Brexit regulatory barrier.
NI Brexit: Supply of medicines to NI fears as end of grace period looms - Health Minister Robin Swann admits he is concerned
22/04/2021
Northern Ireland’s Health Minister Robin Swann has voiced concern about the supply of medicines to the region as a result of a looming Brexit regulatory barrier to securing stock from the rest of the UK.
Post-Brexit issues for the NHS
19/01/2022
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
What will Brexit mean for UK dentistry?
06/04/2017
In the wake of last week’s triggering of Article 50, marking the formal start of Brexit negotiations, and the publication of the ‘Great Reform Bill’ it is a good time to ask what the effect will be on dentistry, both NHS and private.
SCOTLAND'S two chief medical officers has issued a new warning of shortages to the supply of medicines in the event of a 'no deal' Brexit.
Vaccines and blood products could be stockpiled ahead of a possible ‘no-deal’ Brexit, the health and social care secretary has confirmed.
Importing fresh food through the port of Dover would only be the Government’s third highest priority in the event of a no-deal Brexit later this year, it has emerged.
Following the UK’s exit from the EU, the regulatory landscape for medical devices remains uncertain. Andrew Thompson, PhD, director of therapy research & analysis at GlobalData, explains what companies need to know.
Medical devices illustrate the limited scope for post-Brexit UK divergence from EU rules, and the trade-offs the UK must face. / 'Many manufacturers have suggested they will not bother with the additional cost and complexity of putting their devices through the UKCA processes on top of the updated European process.'
The NHS and Brexit: What We Now Know
05/01/2023
Sam Bright examines the contribution of Brexit to our current healthcare crisis.
UK drug distributors and those involved in the parallel importing of drugs have told the parliamentary Health Select Committee that they want to see the UK remain in the customs union and the single market.